The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Comparison of concurrent use of carboplatin-Paclitaxel versus cisplatin-etoposide with thoracic radiation for stage III NSCLC patients: A systematic review.
 
Conor Ernst Steuer
No Relationships to Disclose
 
Madhusmita Behera
No Relationships to Disclose
 
Kristin Ann Higgins
No Relationships to Disclose
 
Nabil F. Saba
No Relationships to Disclose
 
Dong Moon Shin
No Relationships to Disclose
 
Suchita Pakkala
No Relationships to Disclose
 
Rathi Narayana Pillai
No Relationships to Disclose
 
Taofeek Kunle Owonikoko
No Relationships to Disclose
 
Walter John Curran
Stock and Other Ownership Interests - eviti; Nanthealth
Honoraria - Bayer; Bristol-Myers Squibb; Lilly/ImClone
Consulting or Advisory Role - eviti
Research Funding - Abbvie (Inst)
 
Chandra Prakash Belani
No Relationships to Disclose
 
Fadlo Raja Khuri
No Relationships to Disclose
 
Suresh S. Ramalingam
Consulting or Advisory Role - Abbvie; Amgen; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Genentech/Roche; Lilly/ImClone; Novartis
Travel, Accommodations, Expenses - AstraZeneca; EMD Serono; Pfizer